EpiEndo is an Icelandic pharmaceutical and biotech startup company,
primarily focused on solutions to chronic airway diseases. EpiEndo is
the only company targeting Epithelial Barrier Failure (EBF) in
respiratory diseases. Applying the paradigm of the “leaky epithelial
barrier” both diagnostically and therapeutically makes EpiEndo a unique
industry player and has enabled ways to disrupt the status-quo that has
prevailed in the respiratory sector for decades.